Ground Swell Capital’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
Other funds holding PMCB
Ground Swell Capital's PMCB Position: Q3 2026 in Review
Ground Swell Capital opened a new position in PharmaCyte Biotech (PMCB) in Q3 2026: 1,032 shares worth $8.05K. The stake represents 0.02% of the portfolio and ranks #131 among its holdings. This is a return to the name: Ground Swell Capital previously reported a position in PMCB as recently as Q1 2026.
Ground Swell Capital first reported a position in PMCB in Q1 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold PMCB as of Q3 2026.
- Ground Swell Capital held 1,032 shares of PharmaCyte Biotech worth $8.05K as of Q3 2026.
- PharmaCyte Biotech was a new Ground Swell Capital position in Q3 2026.
- PharmaCyte Biotech made up 0.02% of Ground Swell Capital's portfolio in Q3 2026, its #131 holding.
- Ground Swell Capital first reported a position in PharmaCyte Biotech in Q1 2026 and has held it in 2 quarters since.
- 20 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q3 2026.
Based on Ground Swell Capital's 13F filing for Q3 2026, filed 9 Nov 2026.